Well, I've been remiss in not bringing the Immiticide status report up to date since my last post. The FDA has granted a provisional approval to the European supplier of the raw materials for melarsomine. This apparently falls under some sort of "compassionate use" guideline.
The official line now is that we still cannot just buy it from our distributors to keep in stock and have on hand. That would be too easy. However, if we call Merial directly, and order product for a specific patient (name, date of birth, weight, serial number, etc.), we can buy as much as we need.
The thrust of this is that the drug is no longer being rationed for the treatment of sick dogs only. Now we can go ahead and treat the dogs that missed a pill here and there, or where the preventive simply was not 100% effective.
So, we're working through our backlog of about 15 dogs since the first of the year, plus three more this week.